Edward White
Stock Analyst at HC Wainwright & Co.
(1.22)
# 3,411
Out of 4,829 analysts
384
Total ratings
25.76%
Success rate
-10.03%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.98 | +313.53% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $6.42 | +164.80% | 41 | Apr 15, 2025 | |
| INZY Inozyme Pharma | Reiterates: Buy | $16 | $1.18 | +1,255.93% | 14 | Apr 10, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $6.00 | +150.00% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $2.00 | +200.00% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.85 | +764.86% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $2.19 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $4 | $0.34 | +1,065.16% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $2.38 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $2.17 | +821.66% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.36 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $2.10 | +663.72% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.36 | +366.85% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.59 | +403.14% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.03 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.70 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $35.14 | +56.52% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $11.08 | +360.29% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.07 | +128.01% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $6.12 | +815.78% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.05 | +208.46% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.26 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.07 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.36 | +7,658.38% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $18.56 | +61.64% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.07 | +1,021.50% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.98
Upside: +313.53%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $6.42
Upside: +164.80%
Inozyme Pharma
Apr 10, 2025
Reiterates: Buy
Price Target: $16
Current: $1.18
Upside: +1,255.93%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $6.00
Upside: +150.00%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $2.00
Upside: +200.00%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.85
Upside: +764.86%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.19
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.34
Upside: +1,065.16%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.38
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $2.17
Upside: +821.66%
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $2.10
Upside: +663.72%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.36
Upside: +366.85%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.59
Upside: +403.14%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.03
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.70
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $35.14
Upside: +56.52%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $11.08
Upside: +360.29%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $3.07
Upside: +128.01%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $6.12
Upside: +815.78%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.05
Upside: +208.46%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.26
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.07
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.36
Upside: +7,658.38%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $18.56
Upside: +61.64%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.07
Upside: +1,021.50%